Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
INTRODUCTION: Administration of beta-2 agonists decreased bone mineral density in rats. But the association between bronchodilators and fracture risk has not been studied in humans. OBJECTIVES: To examine the association between use of beta-2 agonists and risk of hip/femur fracture. METHODS: We cond...
Main Authors: | de Vries, F, Pouwels, S, Bracke, M, Leufkens, H, Cooper, C, Lammers, J, van Staa, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Use of beta-2 agonists and risk of hip fracture
by: De Vries, F, et al.
Published: (2006) -
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
by: de Vries, F, et al.
Published: (2007) -
Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study.
by: Pouwels, S, et al.
Published: (2009) -
Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
by: de Vries, F, et al.
Published: (2007) -
Risk of hip/femur fracture after stroke: a population-based case-control study.
by: Pouwels, S, et al.
Published: (2009)